These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 15082726)

  • 1. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended lymph-node dissection for gastric cancer.
    Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
    N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.
    Cuschieri A; Weeden S; Fielding J; Bancewicz J; Craven J; Joypaul V; Sydes M; Fayers P
    Br J Cancer; 1999 Mar; 79(9-10):1522-30. PubMed ID: 10188901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Schwarz RE; Smith DD
    J Clin Oncol; 2005 Aug; 23(23):5404-5; author reply 5405. PubMed ID: 16091352
    [No Abstract]   [Full Text] [Related]  

  • 8. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of patients with gastric carcinoma based on the results of Dutch studies].
    Hartgrink HH; van de Velde CJ
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):238-45. PubMed ID: 15719834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of spleen preservation in patients with gastric cancer.
    Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
    Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric carcinoma: does lymph node dissection alter survival?
    Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
    J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymph node excision in cancer of the stomach].
    Msika S
    J Chir (Paris); 1998 Oct; 135(4):155-61. PubMed ID: 9827394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
    Reis E; Kama NA; Doganay M; Atli M; Dolapci M
    Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer.
    McCulloch P; Niita ME; Kazi H; Gama-Rodrigues JJ
    Br J Surg; 2005 Jan; 92(1):5-13. PubMed ID: 15635680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is extended lymph node dissection necessary for gastric cancer in elderly patients?
    Eguchi T; Takahashi Y; Ikarashi M; Kasahara M; Fujii M
    Eur J Surg; 2000 Dec; 166(12):949-53. PubMed ID: 11152256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited effectiveness of extended lymph-node dissection for node-negative patients with proximal gastric cancer.
    Kikuchi S; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Sato K; Kakita A
    Anticancer Res; 2001; 21(2B):1359-62. PubMed ID: 11396213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma.
    Adachi Y; Mimori K; Mori M; Maehara Y; Sugimachi K
    J Am Coll Surg; 1997 Mar; 184(3):240-4. PubMed ID: 9060918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
    Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
    Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended lymphadenectomy in gastric cancer: when, for whom and why.
    Roukos DH
    Ann R Coll Surg Engl; 1998 Jan; 80(1):16-24. PubMed ID: 9579122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.